文献速递产科母胎医学

宫颈托预防高危无症状孕妇早产:系统评价与Meta分析

Cervical pessary to prevent preterm birth in asymptomatic high-risk women: a systematic review and meta-analysis.
PubMed 文献 · Am J Obstet Gynecol · 2020-02-03

该系统评价纳入12项随机对照试验(4687名孕妇),评估宫颈托对无症状高危孕妇早产及围产结局的疗效与安全性。结果显示,宫颈托与不放置宫颈托相比,在单胎宫颈长度≤25mm、双胎(无论是否短宫颈)中均未显著降低<34周自发性早产风险;与阴道孕酮相比亦无显著差异,但阴道分泌物增多风险约增2倍。

要点

  • 宫颈托不降低单胎短宫颈孕妇<34周自发性早产风险(RR 0.80,95%CI 0.43-1.49)。
  • 未选择双胎妊娠中,宫颈托对<34周自发性早产无显著影响(RR 1.05,95%CI 0.79-1.41)。
  • 宫颈托组阴道分泌物显著增多(RR约2.20)。

核心结论

  • 当前证据不支持使用宫颈托预防单胎或双胎短宫颈孕妇及早产高危双胎妊娠的早产或改善围产结局。

研究设计与样本

  • 系统评价与Meta分析,纳入12项随机对照试验,共4687名孕妇和7167名胎儿/婴儿。
  • 8项比较宫颈托与不放置宫颈托在短宫颈孕妇中的效果,2项比较宫颈托与不放置宫颈托在未选择双胎妊娠中的效果,2项比较宫颈托与阴道孕酮在短宫颈孕妇中的效果。

主要发现

  • 单胎宫颈长度≤25mm者,宫颈托组与不放置组<34周自发性早产风险无显著差异(RR 0.80,95%CI 0.43-1.49;6项试验,1982名孕妇;低质量证据)。
  • 未选择双胎妊娠中,两组<34周自发性早产风险无显著差异(RR 1.05,95%CI 0.79-1.41;1项试验,1177名孕妇;中等质量证据)。
  • 双胎宫颈长度<38mm者,两组<34周自发性早产风险无显著差异(RR 0.75,95%CI 0.41-1.36;3项试验,1128名孕妇;低质量证据)。
  • 双胎宫颈长度≤25mm者,两组<34周自发性早产风险无显著差异(RR 0.72,95%CI 0.25-2.06;2项试验,348名孕妇;低质量证据)。
  • 宫颈托组阴道分泌物显著多于不放置组和阴道孕酮组(RR约2.20;高质量证据)。

关键数值与推荐

  • 单胎宫颈长度≤25mm:宫颈托 vs 不放置,<34周自发性早产RR 0.80(95%CI 0.43-1.49)。
  • 未选择双胎妊娠:宫颈托 vs 不放置,<34周自发性早产RR 1.05(95%CI 0.79-1.41)。
  • 双胎宫颈长度<38mm:宫颈托 vs 不放置,<34周自发性早产RR 0.75(95%CI 0.41-1.36)。
  • 双胎宫颈长度≤25mm:宫颈托 vs 不放置,<34周自发性早产RR 0.72(95%CI 0.25-2.06)。
  • 单胎宫颈长度≤25mm:宫颈托 vs 阴道孕酮,<34周自发性早产RR 0.99(95%CI 0.54-1.83;1项试验,246名孕妇;低质量证据)。

临床怎么用

  • 对于无症状短宫颈单胎或双胎妊娠及未选择双胎妊娠,不应常规使用宫颈托预防早产。
  • 使用宫颈托需注意阴道分泌物增多这一不良反应。

局限性

  • 多数结局证据质量为低至中等,部分比较纳入试验少、样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Randomized controlled trials that have assessed the efficacy of cervical pessary to prevent preterm birth in asymptomatic high-risk women have reported conflicting results. OBJECTIVE: To evaluate the efficacy and safety of cervical pessary to prevent preterm birth and adverse perinatal outcomes in asymptomatic high-risk women. DATA SOURCES: MEDLINE, EMBASE, POPLINE, CINAHL, and LILACS (from their inception to October 31, 2019), Cochrane databases, Google Scholar, bibliographies, and conference proceedings. STUDY ELIGIBILITY CRITERIA: Randomized controlled trials that compared cervical pessary with standard care (no pessary) or alternative interventions in asymptomatic women at high risk for preterm birth. STUDY APPRAISAL AND SYNTHESIS METHODS: The systematic review was conducted according to the Cochrane Handbook guidelines. The primary outcome was spontaneous preterm birth <34 weeks of gestation. Secondary outcomes included adverse pregnancy, maternal, and perinatal outcomes. Pooled relative risks with 95% confidence intervals were calculated. Quality of evidence was assessed using the GRADE methodology. RESULTS: Twelve studies (4687 women and 7167 fetuses/infants) met the inclusion criteria: 8 evaluated pessary vs no pessary in women with a short cervix, 2 assessed pessary vs no pessary in unselected multiple gestations, and 2 compared pessary vs vaginal progesterone in women with a short cervix. There were no significant differences between the pessary and no pessary groups in the risk of spontaneous preterm birth <34 weeks of gestation among singleton gestations with a cervical length ≤25 mm (relative risk, 0.80; 95% confidence interval, 0.43-1.49; 6 trials, 1982 women; low-quality evidence), unselected twin gestations (relative risk, 1.05; 95% confidence interval, 0.79-1.41; 1 trial, 1177 women; moderate-quality evidence), twin gestations with a cervical length <38 mm (relative risk, 0.75; 95% confidence interval, 0.41-1.36; 3 trials, 1128 women; low-quality evidence), and twin gestations with a cervical length ≤25 mm (relative risk; 0.72, 95% confidence interval, 0.25-2.06; 2 trials, 348 women; low-quality evidence). Overall, no significant differences were observed between the pessary and no pessary groups in preterm birth <37, <32, and <28 weeks of gestation, and most adverse pregnancy, maternal, and perinatal outcomes (low- to moderate-quality evidence for most outcomes). There were no significant differences in the risk of spontaneous preterm birth <34 weeks of gestation between pessary and vaginal progesterone in singleton gestations with a cervical length ≤25 mm (relative risk, 0.99; 95% confidence interval, 0.54-1.83; 1 trial, 246 women; low-quality evidence) and twin gestations with a cervical length <38 mm (relative risk, 0.73; 95% confidence interval, 0.46-1.18; 1 trial, 297 women; very low-quality evidence). Vaginal discharge was significantly more frequent in the pessary group than in the no pessary and vaginal progesterone groups (relative risks, ∼2.20; high-quality evidence). CONCLUSION: Current evidence does not support the use of cervical pessary to prevent preterm birth or to improve perinatal outcomes in singleton or twin gestations with a short cervix and in unselected twin gestations.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Conde-Agudelo A, Romero R, Nicolaides KH, et al. Cervical pessary to prevent preterm birth in asymptomatic high-risk women: a systematic review and meta-analysis. Am J Obstet Gynecol. 2020. PMID: 32027880. doi:10.1016/j.ajog.2019.12.266

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。